InfraRx

Headquarters

Philadelphia, PA

InfraRx is America's only clinically proven, FDA approved, prescription-only Infrared Heat Pad System. The company manufactures a non-opioid, non-invasive treatment device to reduce chronic pain by more than 50%.

• MAXONA Pharmaceuticals, IncMAXONA Pharmaceuticals is a clinical-stage pharmaceutical company leveraging innovation to develop the next generation of therapies to help patients maximize life. MAXONA's initial focus is on addressing the urgent need for new effective therapies that treat acute and chronic pain, without the side effects and addiction risks associated with NSAIDS and opioids. MAXONA's lead compound, MAX-001 is a non-opioid, non-NSAID oral therapy with a novel mechanism of action that is initially being developed in the U.S. to treat acute and chronic pain.MALVERN, PA
• Neuropathix, IncNeuropathix, Inc. is a biopharmaceutical company focused on the research and development of a pipeline of next generation breakthrough therapeutics targeting inflammation to treat patients with significant unmet medical needs. The company's lead candidate is KLS-13019, a patented, non-opioid cannabinoid derivative for neuropathic pain.DOYLESTOWN, PA
• Baudax BioBaudax Bio is a revenue-generating, specialty pharmaceutical company focused on developing and commercializing innovative products for acute care settings. The company has multiple non-opioid therapeutics in clinical development for pain conditions and is currently promoting their lead product, ANJESO™, for management of moderate-to-severe pain.MALVERN, PA
• PainTracePainTrace develops and manufactures a wearable medical device that detects, quantifies, and tracks acute and chronic pain through non-invasive biosignal monitoring. The system is used in veterinary and clinical settings to visualize pain in real time and evaluate treatment efficacy.PHILADELPHIA, PA